Third, while TGF-β1 stimulation was employed in vitro to mimic inflammatory and proliferative responses relevant to pterygium development, we acknowledge that it does not fully capture the immunopathological complexity of COVID-19. The gene discussed is TGFB1; the disease is pterygium.